Peiying Yang
Impact in
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
Papers in
-
- Peroxisome Proliferator-Activated Receptors 9
- Pharmacology 53
- Inflammatory mediators and NSAID effects 48
- Co-authors
- Robert A. Newman (60 shared papers)Susan M. Fischer (13 shared papers)Lorenzo Cohen (22 shared papers)Carrie Cartwright (15 shared papers)Diana Chan (12 shared papers)Edward Felix (8 shared papers)Timothy Madden (6 shared papers)Imad Shureiqi (11 shared papers)
- Journals
- Cancer Research (15 papers)Integrative Cancer Therapies (7 papers)Cancer Prevention Research (6 papers)Oncotarget (6 papers)Oncogene (5 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Peiying Yang
161 papers receiving 5.5k citations
Peiying Yang's Hit Papers
Peers
Comparison fields: 5 of 136
- Biochemistry 610
- Pharmacology 1.2k
- Cancer Research 931
- Toxicology 134
- Complementary and alternative medicine 303
Countries citing papers authored by Peiying Yang
This map shows the geographic impact of Peiying Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiying Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiying Yang more than expected).
Fields of papers citing papers by Peiying Yang
This network shows the impact of papers produced by Peiying Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiying Yang. The network helps show where Peiying Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Peiying Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase Hit paper breakdown → | 2017 | 396 |
| 2 | 2009 | 246 | |
| 3 | 2013 | 227 | |
| 4 | 2005 | 185 | |
| 5 | 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. | 2000 | 162 |
| 6 | 2005 | 114 | |
| 7 | 2008 | 114 | |
| 8 | 2007 | 112 | |
| 9 | 2002 | 105 | |
| 10 | 2001 | 99 | |
| 11 | 2004 | 93 | |
| 12 | 2007 | 88 | |
| 13 | 2011 | 82 | |
| 14 | 2005 | 78 | |
| 15 | 2002 | 77 | |
| 16 | 2009 | 76 | |
| 17 | 2012 | 76 | |
| 18 | 2014 | 75 | |
| 19 | Oleandrin-mediated oxidative stress in human melanoma cells. | 2006 | 72 |
| 20 | 2016 | 71 |
About Peiying Yang
Peiying Yang is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Oncology and Genetics, having authored 166 papers that have together received 5.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (48 papers), Estrogen and related hormone effects (17 papers), Eicosanoids and Hypertension Pharmacology (14 papers), Cancer, Lipids, and Metabolism (13 papers), Cancer, Stress, Anesthesia, and Immune Response (11 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Fatty Acid Research and Health (7 papers) and Bioactive Compounds and Antitumor Agents (5 papers). The work is most often cited by research in Biochemistry (610 citations), Pharmacology (1.2k citations), Cancer Research (931 citations), Toxicology (134 citations) and Complementary and alternative medicine (303 citations). Peiying Yang has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Robert A. Newman, Susan M. Fischer, Lorenzo Cohen, Carrie Cartwright, Diana Chan, Edward Felix, Timothy Madden, Imad Shureiqi, David G. Menter and Scott M. Lippman. Their work appears in journals such as Cancer Research, Integrative Cancer Therapies, Cancer Prevention Research, Oncotarget and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.